✦ LIBER ✦

Phase II study of epirubicin (EPI) and lonidamine (LND) in advanced breast cancer

✍ Scribed by Martini, M.C.; Pastorino, G.; Moraglio, L.; Vallauri, M.; Brema, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lonidamine plus epirubicin and cyclophos

✍ G. Gardin; C. Barone; O. Nascimben; G. Ianniello; F. Sturba; A. Contu; P. Pronza 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Phase II study of high-dose epirubicin,

✍ Rosario Vincenzo Iaffaioli; Anna Tortoriello; Gaetano Facchini; Michele Santange 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 545 KB

Phase II study of lonidamine in metastat

✍ Pronzato, P; Amoroso, D; Bertelli, G; Conte, PF; Cusimano, MP; Ciottoli, GB; Gul 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 540 KB

Chemotherapy with MACC and lonidamine (L

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Lonidamine, alpha 2B interferon and high

✍ Iaffaioli, R.V.; Tortoriello, A.; Facchini, G.; Gesue, G.; Pezzullo, L.; Persico 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 166 KB

A phase II trial of paclitaxel and epiru

✍ Rischin, D; Smith, J; Millward, M; Lewis, C; Boyer, M; Richardson, G; Toner, G; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB